177 related articles for article (PubMed ID: 16105689)
1. Antibodies and PMBC from EIAV infected carrier horses recognize gp45 and p26 synthetic peptides.
Soutullo A; García MI; Bailat A; Racca A; Tonarelli G; Malan Borel I
Vet Immunol Immunopathol; 2005 Dec; 108(3-4):335-43. PubMed ID: 16105689
[TBL] [Abstract][Full Text] [Related]
2. Effect of two synthetic peptides mimicking conserved regions of equine infectious anemia virus proteins gp90 and gp45 upon cytokine mRNA expression.
Bailat AS; Soutullo AR; García MI; Veaute CM; Garcia L; Racca AL; Malan Borel IS
Arch Virol; 2008; 153(10):1909-15. PubMed ID: 18825485
[TBL] [Abstract][Full Text] [Related]
3. Control of equine infectious anemia virus is not dependent on ADCC mediating antibodies.
Tschetter JR; Byrne KM; Perryman LE; McGuire TC
Virology; 1997 Apr; 230(2):275-80. PubMed ID: 9143283
[TBL] [Abstract][Full Text] [Related]
4. Frequency of memory cytotoxic T lymphocytes to equine infectious anemia virus proteins in blood from carrier horses.
McGuire TC; Zhang W; Hines MT; Henney PJ; Byrne KM
Virology; 1997 Nov; 238(1):85-93. PubMed ID: 9375012
[TBL] [Abstract][Full Text] [Related]
5. Equine infectious anemia virus (EIAV) humoral responses of recipient ponies and antigenic variation during persistent infection.
Rwambo PM; Issel CJ; Adams WV; Hussain KA; Miller M; Montelaro RC
Arch Virol; 1990; 111(3-4):199-212. PubMed ID: 2162160
[TBL] [Abstract][Full Text] [Related]
6. An attenuated EIAV vaccine strain induces significantly different immune responses from its pathogenic parental strain although with similar in vivo replication pattern.
Lin YZ; Shen RX; Zhu ZY; Deng XL; Cao XZ; Wang XF; Ma J; Jiang CG; Zhao LP; Lv XL; Shao YM; Zhou JH
Antiviral Res; 2011 Nov; 92(2):292-304. PubMed ID: 21893100
[TBL] [Abstract][Full Text] [Related]
7. In vitro antibody-dependent enhancement assays are insensitive indicators of in vivo vaccine enhancement of equine infectious anemia virus.
Raabe ML; Issel CJ; Montelaro RC
Virology; 1999 Jul; 259(2):416-27. PubMed ID: 10388665
[TBL] [Abstract][Full Text] [Related]
8. Gag protein epitopes recognized by CD4(+) T-helper lymphocytes from equine infectious anemia virus-infected carrier horses.
Lonning SM; Zhang W; McGuire TC
J Virol; 1999 May; 73(5):4257-65. PubMed ID: 10196322
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of antibody parameters as potential correlates of protection or enhancement by experimental vaccines to equine infectious anemia virus.
Hammond SA; Raabe ML; Issel CJ; Montelaro RC
Virology; 1999 Sep; 262(2):416-30. PubMed ID: 10502520
[TBL] [Abstract][Full Text] [Related]
10. Genetic immunization with codon-optimized equine infectious anemia virus (EIAV) surface unit (SU) envelope protein gene sequences stimulates immune responses in ponies.
Cook RF; Cook SJ; Bolin PS; Howe LJ; Zhou W; Montelaro RC; Issel CJ
Vet Microbiol; 2005 Jun; 108(1-2):23-37. PubMed ID: 15885929
[TBL] [Abstract][Full Text] [Related]
11. Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection.
Zhang W; Lonning SM; McGuire TC
J Virol; 1998 Dec; 72(12):9612-20. PubMed ID: 9811694
[TBL] [Abstract][Full Text] [Related]
12. [Expression and immunogenicity of equine infectious anemia virus membrane protein GP90].
Dai CB; Xiao Y; Lu H; Shen RX; Shao YM
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Mar; 17(1):73-6. PubMed ID: 12870025
[TBL] [Abstract][Full Text] [Related]
13. Fine specificity of equine infectious anaemia virus gp90-specific antibodies associated with protective and enhancing immune responses in experimentally infected and immunized ponies.
Grund CH; Lechman ER; Pezzuolo NA; Issel CJ; Montelaro RC
J Gen Virol; 1996 Mar; 77 ( Pt 3)():435-42. PubMed ID: 8601778
[TBL] [Abstract][Full Text] [Related]
14. Systematic epitope analysis of the p26 EIAV core protein.
Soutullo A; Santi MN; Perin JC; Beltramini LM; Borel IM; Frank R; Tonarelli GG
J Mol Recognit; 2007; 20(4):227-37. PubMed ID: 17705340
[TBL] [Abstract][Full Text] [Related]
15. Transient immune suppression of inapparent carriers infected with a principal neutralizing domain-deficient equine infectious anaemia virus induces neutralizing antibodies and lowers steady-state virus replication.
Craigo JK; Leroux C; Howe L; Steckbeck JD; Cook SJ; Issel CJ; Montelaro RC
J Gen Virol; 2002 Jun; 83(Pt 6):1353-1359. PubMed ID: 12029150
[TBL] [Abstract][Full Text] [Related]
16. Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.
Tagmyer TL; Craigo JK; Cook SJ; Issel CJ; Montelaro RC
J Gen Virol; 2007 Apr; 88(Pt 4):1324-1336. PubMed ID: 17374779
[TBL] [Abstract][Full Text] [Related]
17. The determination of in vivo envelope-specific cell-mediated immune responses in equine infectious anemia virus-infected ponies.
Liu C; Cook FR; Cook SJ; Craigo JK; Even DL; Issel CJ; Montelaro RC; Horohov DW
Vet Immunol Immunopathol; 2012 Aug; 148(3-4):302-10. PubMed ID: 22795699
[TBL] [Abstract][Full Text] [Related]
18. Identification of broadly recognized, T helper 1 lymphocyte epitopes in an equine lentivirus.
Fraser DG; Oaks JL; Brown WC; McGuire TC
Immunology; 2002 Mar; 105(3):295-305. PubMed ID: 11918691
[TBL] [Abstract][Full Text] [Related]
19. A particulate viral protein vaccine reduces viral load and delays progression to disease in immunized ponies challenged with equine infectious anemia virus.
Hammond SA; Cook SJ; Falo LD; Issel CJ; Montelaro RC
Virology; 1999 Feb; 254(1):37-49. PubMed ID: 9927572
[TBL] [Abstract][Full Text] [Related]
20. Antigenic analysis of equine infectious anemia virus (EIAV) variants by using monoclonal antibodies: epitopes of glycoprotein gp90 of EIAV stimulate neutralizing antibodies.
Hussain KA; Issel CJ; Schnorr KL; Rwambo PM; Montelaro RC
J Virol; 1987 Oct; 61(10):2956-61. PubMed ID: 2442410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
